Sinead Brophy1, Jonathan Kennedy1, Fabiola Fernandez-Gutierrez2, Ann John3, Robert Potter4, Christine Linehan5, Michael Kerr6. 1. 1 FARR Institute (CIPHER), Swansea University Medical School , Swansea, United Kingdom . 2. 2 Swansea University Medical School , Swansea, United Kingdom . 3. 3 Population Psychiatry, Suicide and Informatics, FARR Institute (CIPHER), Swansea University Medical School , Swansea, United Kingdom . 4. 4 Cwm Taf Health University Health Board and Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University School of Medicine , Cardiff, Wales. 5. 5 UCD Centre for Disability Studies, University College Dublin , Dublin, Ireland . 6. 6 Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University School of Medicine , Cardiff, Wales.
Abstract
OBJECTIVE: Antipsychotics are licensed for psychosis and are also prescribed for behavior control. This study aims to examine characteristics and outcomes of children prescribed antipsychotics. METHODS: A cohort study using general practice and hospital records linked with education records for 1,488,936 children living in Wales between 1999 and 2015. The characteristics of the children who were prescribed antipsychotics are presented using descriptive statistics and outcomes such as respiratory illness, diabetes, and injury were analyzed using multilevel logistic regression and the prior event rate ratio (PERR). RESULTS: Children with intellectual difficulty/autism were more likely to be prescribed antipsychotics (2.8% have been prescribed an antipsychotic [75% with autism] compared with 0.15% of children without intellectual difficulty). Those with intellectual disabilities/autism were prescribed antipsychotics at a younger age and for a longer period. Antipsychotic use was associated with a higher rate of respiratory illness for all (PERR of hospital admission: 1.55 [95% CI: 1.51-1.598] or increase in rate of 2 per 100 per year in those treated), and for those with intellectual difficulty/autism, there was a higher rate of injury and hospitalized depression. However, among those without intellectual difficulty/autism, there were lower rates of depression (PERR: 0.55 [95% CI: 0.51-0.59]). CONCLUSIONS: This work shows real-world use of antipsychotics and provides information on the rate of possible adverse events in children treated. Antipsychotics are predominantly used for those with intellectual difficulty/autism rather than those with a psychotic diagnosis. There is evidence that rates of respiratory disease, epilepsy, and diabetes are also higher postantipsychotic use for all. In those with intellectual difficulty/autism, hospital-admitted depression and injury are higher postantipsychotic use. The use of antipsychotics for behavioral management is likely to have increased cost implications to the healthcare system.
OBJECTIVE: Antipsychotics are licensed for psychosis and are also prescribed for behavior control. This study aims to examine characteristics and outcomes of children prescribed antipsychotics. METHODS: A cohort study using general practice and hospital records linked with education records for 1,488,936 children living in Wales between 1999 and 2015. The characteristics of the children who were prescribed antipsychotics are presented using descriptive statistics and outcomes such as respiratory illness, diabetes, and injury were analyzed using multilevel logistic regression and the prior event rate ratio (PERR). RESULTS:Children with intellectual difficulty/autism were more likely to be prescribed antipsychotics (2.8% have been prescribed an antipsychotic [75% with autism] compared with 0.15% of children without intellectual difficulty). Those with intellectual disabilities/autism were prescribed antipsychotics at a younger age and for a longer period. Antipsychotic use was associated with a higher rate of respiratory illness for all (PERR of hospital admission: 1.55 [95% CI: 1.51-1.598] or increase in rate of 2 per 100 per year in those treated), and for those with intellectual difficulty/autism, there was a higher rate of injury and hospitalized depression. However, among those without intellectual difficulty/autism, there were lower rates of depression (PERR: 0.55 [95% CI: 0.51-0.59]). CONCLUSIONS: This work shows real-world use of antipsychotics and provides information on the rate of possible adverse events in children treated. Antipsychotics are predominantly used for those with intellectual difficulty/autism rather than those with a psychotic diagnosis. There is evidence that rates of respiratory disease, epilepsy, and diabetes are also higher postantipsychotic use for all. In those with intellectual difficulty/autism, hospital-admitted depression and injury are higher postantipsychotic use. The use of antipsychotics for behavioral management is likely to have increased cost implications to the healthcare system.
Entities:
Keywords:
antipsychotic; intellectual difficulty; prior event rate ratio; routine data
Authors: Luuk J Kalverdijk; Hilde Tobi; Paul B van den Berg; Janelle Buiskool; Leonie Wagenaar; Ruud B Minderaa; Lolkje T W de Jong-van den Berg Journal: Psychiatr Serv Date: 2008-05 Impact factor: 3.084
Authors: Md Jamal Uddin; Rolf H H Groenwold; Tjeerd P van Staa; Anthonius de Boer; Svetlana V Belitser; Arno W Hoes; Kit C B Roes; Olaf H Klungel Journal: Pharmacoepidemiol Drug Saf Date: 2014-11-20 Impact factor: 2.890
Authors: Kyle Morrow; Keith A Young; Shawn Spencer; Edgar Samuel Medina; Michaela A Marziale; Alejandro Sanchez; James A Bourgeois Journal: Proc (Bayl Univ Med Cent) Date: 2020-10-06
Authors: Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa; Mohammad Qasaymeh; Shadi Qasem; Emily De Los Reyes Journal: Neuropsychiatr Dis Treat Date: 2020-11-16 Impact factor: 2.570
Authors: Kimberley M Kendall; Ann John; Sze Chim Lee; Elliott Rees; Antonio F Pardiñas; Marcos Del Pozo Banos; Michael J Owen; Michael C O'Donovan; George Kirov; Keith Lloyd; Ian Jones; Sophie E Legge; James T R Walters Journal: BJPsych Open Date: 2020-11-10
Authors: Yishu Liu; Shaoming Xiao; Xuejun Yin; Pei Gao; Jing Wu; Shangzhi Xiong; Carinna Hockham; Thomas Hone; Jason H Y Wu; Sallie Anne Pearson; Bruce Neal; Maoyi Tian Journal: Public Health Rev Date: 2022-09-21